An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an Autoinjector

Clinical trial NCT06994936 · COMPLETED

Trial details

NCT number: NCT06994936
Sponsor: MoonLake Immunotherapeutics AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relative Bioequivalence

Start date: 2025-06-05
Primary completion: 2025-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.